World Orphan Drug Congress USA 2025
Date: April 22nd–24th, 2025
Location: Boston, USA
PharSafer® is delighted to confirm our participation in the World Orphan Drug Congress USA 2025, one of the foremost global events dedicated to orphan drug development, rare disease research, and regulatory innovation.
Exclusive Speaker Session
Join Dr. Graeme Ladds, CEO of PharSafer®, for his keynote presentation:
“Safety & Compliance Without Borders: The Orphan Drug Safety Regulatory Checklist”
In this must-attend session, Dr. Ladds will share expert guidance on building a compliant global safety strategy for orphan and ultra-orphan drug development — from early clinical trials to long-term post-marketing surveillance. Drawing from decades of regulatory experience, this talk explores:
Ideal for: Regulatory affairs professionals, rare disease developers, PV leaders, clinical operations teams, and biotech innovators looking to expand globally while remaining compliant.
Attendees will leave with a deeper understanding of global safety challenges — and a clear checklist to enhance compliance readiness across international markets.
Connect with PharSafer® in Boston
Our senior team will be available throughout the event and would welcome the opportunity to discuss your organisation’s challenges and explore tailored solutions across:
Schedule a Meeting
To ensure a dedicated time with our experts, we encourage you to schedule your meeting with us in advance.
We look forward to connecting with you in Boston for an inspiring and impactful event.
Note: For more information about the event, please visit: World Orphan Drug Congress 2025.